Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France

We aimed to assess the factors associated with mortality in patients treated with tocilizumab for a SARS-CoV-2 pneumonia due to the delta or omicron variants of concern (VOC) and detect an effect of tocilizumab on mortality. We conducted a prospective cohort study in a tertiary hospital from 1 Augus...

Descripción completa

Detalles Bibliográficos
Autores principales: Laffont-Lozes, Paul, Laureillard, Didier, Loubet, Paul, Stephan, Robin, Chiaruzzi, Myriam, Clemmer, Edouard, Martin, Aurelie, Roger, Claire, Muller, Laurent, Claret, Pierre-Géraud, Goulabchand, Radjiv, Roux, Clarisse, Lavigne, Jean-Philippe, Sotto, Albert, Larcher, Romaric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854884/
https://www.ncbi.nlm.nih.gov/pubmed/36671288
http://dx.doi.org/10.3390/antibiotics12010088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854884/
https://www.ncbi.nlm.nih.gov/pubmed/36671288
http://dx.doi.org/10.3390/antibiotics12010088

Ejemplares similares